XML 102 R10.htm IDEA: XBRL DOCUMENT v3.20.1
Marketable Securities
12 Months Ended
Mar. 28, 2020
Marketable Securities [Abstract]  
Marketable Securities Marketable Securities
The Company’s investments have been classified as available-for-sale securities in accordance with U.S. GAAP. Marketable securities are categorized on the Consolidated Balance Sheet as “Marketable securities” within the short-term or long-term classification, as appropriate.
The following table is a summary of available-for-sale securities (in thousands):
 
As of March 28, 2020Amortized
Cost
Gross Unrealized
Gains
Gross Unrealized
Losses
Estimated Fair Value
(Net Carrying Amount)
Corporate debt securities$286,668  $1,157  $(3,993) $283,832  
Non-US government securities12,483  260  —  12,743  
US Treasury securities8,839  167  —  9,006  
Total securities$307,990  $1,584  $(3,993) $305,581  
The Company typically invests in highly-rated securities with original maturities generally ranging from one to three years. The Company's specifically identified certain securities with a total gross unrealized loss of $4.0 million at March 28, 2020. The total amortized cost of these securities was approximately $172.9 million. There were no securities that have been in a continuous unrealized loss position for more than 12 months as of March 28, 2020. The Company may sell certain of its marketable securities prior to their stated maturities for strategic reasons including, but not limited to, anticipated or actual changes in credit rating and duration management.  When evaluating an investment for other-than-temporary impairment, the Company reviews factors including the length of time and extent to which fair value has been below cost basis, the financial condition of the issuer, changes in market interest rates and whether it is more likely than not the Company will be required to sell the investment before recovery of the investment’s cost basis. As of March 28, 2020, the Company does not consider any of its investments to be other-than-temporarily impaired.
 
As of March 30, 2019Amortized
Cost
Gross Unrealized
Gains
Gross Unrealized
Losses
Estimated Fair Value
(Net Carrying Amount)
Corporate debt securities$215,098  $1,027  $(600) $215,525  
Non-US government securities13,209   (40) 13,177  
Agency discount notes450  —  (1) 449  
Total securities$228,757  $1,035  $(641) $229,151  
The Company’s specifically identified certain securities with a total gross unrealized losses of $0.6 million at March 30, 2019. The total amortized cost of these securities was approximately $123.1 million. Securities in a continuous unrealized loss position for more than 12 months as of March 30, 2019 had an aggregate amortized cost of $120.3 million and an aggregate unrealized loss of $0.6 million. As of March 30, 2019, the Company did not consider any of its investments to be other-than-temporarily impaired.
The cost and estimated fair value of available-for-sale investments by contractual maturity were as follows:
 
 March 28, 2020March 30, 2019
Amortized
Cost
Estimated
Fair Value
Amortized
Cost
Estimated
Fair Value
Within 1 year$22,012  $22,008  $70,490  $70,183  
After 1 year285,978  283,573  158,267  158,968  
Total$307,990  $305,581  $228,757  $229,151